Drug Type Stapled peptide |
Synonyms Bilpatide, RAY 002, RAY 1225 + [3] |
Target |
Action agonists |
Mechanism GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 3 | China | 22 Aug 2025 | |
| Obesity | Phase 3 | China | 15 Jun 2025 | |
| Metabolic Dysfunction Associated Steatohepatitis | Phase 3 | China | - | |
| Hepatic Insufficiency | Phase 1 | China | 26 Aug 2024 | |
| Liver Injury | Phase 1 | China | 26 Aug 2024 | |
| Sleep Apnea, Obstructive | IND Approval | China | 23 Jan 2026 |
Phase 2 | 132 | RAY1225 3mg | flggdtfnlx(pjjyxeoieb) = upmwkgitdk nxplwflmvt (gfkzdieswr, -11.63 to -8.49) | Positive | 20 Jun 2025 | ||
RAY1225 6mg | flggdtfnlx(pjjyxeoieb) = furqnpipxw nxplwflmvt (gfkzdieswr, -14.51 to -11.43) | ||||||
SHINING-1 (NEWS) Manual | Phase 2 | - | ycskqacxui(ziwaxcegzz) = zlswjkyqnx pjlpthzvvh (duiyaeiafc ) Met View more | Positive | 31 Dec 2024 | ||
ycskqacxui(ziwaxcegzz) = bgiskbeclp pjlpthzvvh (duiyaeiafc ) Met View more | |||||||
REBUILDING-1 (NEWS) Manual | Phase 2 | 122 | RAY1225注射液 3mg | huzzmkouae(ulbxwueoiu) = nxgzofcgku guefqsdvjx (oedmyjryxz ) View more | Positive | 21 Nov 2024 | |
RAY1225注射液 6mg | huzzmkouae(ulbxwueoiu) = hgzyxtgctg guefqsdvjx (oedmyjryxz ) View more |






